31-08-2016 | Cardiology | News | Article
ICDs fail to reduce long-term mortality in non-ischaemic HF
Prophylactic implantable cardioverter–defibrillator use does not reduce long-term mortality in patients with symptomatic heart failure not caused by coronary artery disease, Danish research shows.
N Engl J Med 2016; Advance online publication
12-08-2016 | Cardiology | News | Article
Racial and gender disparities common in ICD counselling
Less than a quarter of heart failure (HF) patients eligible for implantable cardioverter-defibrillator counselling actually receive it, with the rates even lower in women and ethnic minority patients, an observational analysis of the Get With The Guidelines-HF Program shows.
Circulation 2016; Advance online publication
29-07-2016 | Heart failure | News | Article
HF patients rarely tested for CAD
Tests for ischaemic coronary artery disease are badly underutilised in patients with new-onset heart failure, research shows.
J Am Coll Cardiol 2016; 68: 450–458, 459–460
15-07-2016 | Heart failure | News | Article
Post-MI heart failure increases cancer risk
Myocardial infarction survivors who have heart failure are more likely to develop cancer than their heart failure-free counterparts, indicates research published in the Journal of the American College of Cardiology.
J Am Coll Cardiol 2016; 68: 265–271, 272–273
13-07-2016 | Heart failure | News | Article
Sacubitril plus valsartan reduces early readmission risk in HF
The risk of readmission within 30 days of heart failure hospitalisation is reduced by a quarter for patients receiving sacubitril/valsartan compared with those receiving enalapril, an analysis of PARADIGM-HF trial data shows.
J Am Coll Cardiol 2016; 68: 241–248, 249–251
05-07-2016 | Heart failure | News | Article
Anaemia in heart failure may impact prognosis
Anaemia is common in patients with heart failure, regardless of the underlying phenotype, and is often associated with iron deficiency, UK researchers report.
JAMA Cardiol 2016; Advance online publication
27-06-2016 | Heart failure | News | Article
Elevated troponin I should not rule out donor hearts
Donor cardiac troponin I level is not associated with intermediate-term mortality, cardiac allograft vasculopathy or primary graft failure in patients receiving heart transplants, US researchers report.
Circ Heart Fail 2016; Advance online publication